Eli Lilly and Co.'s potential once-weekly treatment for type 2 diabetes fared better than three other drugs in lowering blood sugar...

We  know that,   Riociguat  ( BAY 63-2521, below structure ) is a novel drug that is currently in clinical development by  Bayer . It is a...

We know that,  Fycompa (see structure, perampanel) is a selective, non-competitive AMPA receptor antagonist discovered by the research...

We know that,  Ceratonia siliqua , commonly known as the   Carob tree   and   St John's-bread ,     is a species of   floweringevergre...

Tarsa Therapeutics Inc. announced that a Phase 2 trial of its oral recombinant salmon calcitonin in the prevention of postmenopausal osteo...

We know that, Trastuzumab emtansine (INN, also called trastuzumab-DM1 or trastuzumab-MCC-DM1 , abbreviated T-DM1 ) is an antibody-dru...

Oxtellar  XR  is Oxcarbazepine Extended-Release Tablets... We know that,  Oxcarbazepine    is an  anticonvulsant  and  mood stabilizi...

Astex Begins Phase 2 Cancer Trial of  SGI-110 | News | Drug Discovery and Development Magazine

We know that, Empagliflozin (see structure) is a SGLT2 inhibitor which is being investigated in clinical trials for the oral treatment ...

We know that,  Tivozanib  (see structure below, AV-951) is an oral VEGF receptor tyrosine kinase inhibitor. It is undergoing clinical tria...

In continuation of my update on cherries C herry intake reduces risk of gout attacks

In continuation of my update on Ganetespib .... "The preliminary results from GALAXY indicate that the addition of ganetespib t...

In continuation of my update on V emurafenib .. A Phase I study in 44 patients shows that the combination of the MEK inhibitor GDC-0...

We know that,  AP26113 (see structure) is a highly potent ALK inhibitor with IC50 of 0.62 nM. As an ALK inhibitor, AP26113 overcomes mu...

In continuation of my update on  dabrafenib and trametinib ..... Combination of targeted treatment drugs delays resistance in melanoma ...